China Healthwise Holdings Ltd.

As of December 31, 2024, China Healthwise Holdings Ltd. carries a market capitalization of 119.42M, placing it among publicly traded companies globally. Its enterprise value stands at 178.45M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, China Healthwise Holdings Ltd. has 770.48M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, China Healthwise Holdings Ltd. maintains a current ratio of 1.55, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on September 18, 2026, China Healthwise Holdings Ltd.'s stock has declined approximately 50.67% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.11.

As of December 31, 2024, China Healthwise Holdings Ltd. holds 44.72M in cash and equivalents against 103.74M in total debt, resulting in a net debt position of 86.17M. Total book value stands at -18.38M, with working capital of 40.25M providing operational flexibility.

China Healthwise Holdings Ltd.'s most recent stock split took place on October 19, 2020 with a 10:1 split ratio.